ID

22666

Description

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00600587

Link

https://clinicaltrials.gov/show/NCT00600587

Keywords

  1. 6/9/17 6/9/17 -
Uploaded on

June 9, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587

Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Description

ID.1

Data type

boolean

Alias
UMLS CUI [1]
C0021430
histological or cytological documented
Description

ID.2

Data type

boolean

Alias
UMLS CUI [1,1]
C0449575
UMLS CUI [1,2]
C0205471
UMLS CUI [1,3]
C0007131
resectable nsclc of stage iiia-n2 confirmed by mediastinoscopy or pet
Description

ID.3

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1300072
naive therapy nsclc
Description

ID.4

Data type

boolean

Alias
UMLS CUI [1]
C0919936
candidates should be tolerated with induction therapy and thoracotomy with ecog performance status 0-2, adequate haematological and hepatic- renal function and qualified lung function
Description

ID.5

Data type

boolean

Alias
UMLS CUI [1,1]
C1520224
UMLS CUI [1,2]
C0678852
UMLS CUI [1,3]
C0857127
enough tissue samples to perform gene analysis
Description

ID.6

Data type

boolean

Alias
UMLS CUI [1,1]
C3267141
UMLS CUI [1,2]
C0475358
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
small cell lung cancer
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1]
C0149925
pregnant or breast-feeding women
Description

ID.8

Data type

boolean

Alias
UMLS CUI [1,1]
C0549206
UMLS CUI [1,2]
C0006147
any unstable systemic disease
Description

ID.9

Data type

boolean

Alias
UMLS CUI [1]
C1385002
patients with exposure to investigational drug therapy or other concurrent anticancer therapy outside of this trial
Description

ID.10

Data type

boolean

Alias
UMLS CUI [1]
C0008976

Similar models

Eligibility Carcinoma, Non-Small-Cell Lung NCT00600587

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
ID.2
Item
histological or cytological documented
boolean
C0449575 (UMLS CUI [1,1])
C0205471 (UMLS CUI [1,2])
C0007131 (UMLS CUI [1,3])
ID.3
Item
resectable nsclc of stage iiia-n2 confirmed by mediastinoscopy or pet
boolean
C0007131 (UMLS CUI [1,1])
C1300072 (UMLS CUI [1,2])
ID.4
Item
naive therapy nsclc
boolean
C0919936 (UMLS CUI [1])
ID.5
Item
candidates should be tolerated with induction therapy and thoracotomy with ecog performance status 0-2, adequate haematological and hepatic- renal function and qualified lung function
boolean
C1520224 (UMLS CUI [1,1])
C0678852 (UMLS CUI [1,2])
C0857127 (UMLS CUI [1,3])
ID.6
Item
enough tissue samples to perform gene analysis
boolean
C3267141 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
small cell lung cancer
boolean
C0149925 (UMLS CUI [1])
ID.8
Item
pregnant or breast-feeding women
boolean
C0549206 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
ID.9
Item
any unstable systemic disease
boolean
C1385002 (UMLS CUI [1])
ID.10
Item
patients with exposure to investigational drug therapy or other concurrent anticancer therapy outside of this trial
boolean
C0008976 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial